Kymera Therapeutics, Inc. (KYMR)

80.69 -0.38 (-0.47%) USD  |  NASDAQ  |  May 01, 16:00
80.69 0.00 (0.00%) After-Hours: 20:00
More

Kymera Therapeutics Price to CFO Per Share (TTM)

Price to CFO Per Share (TTM) Chart

View Price to CFO Per Share (TTM) for KYMR.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Price to CFO Per Share (TTM) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Price to CFO Per Share (TTM) Range, Past 5 Years

View Price to CFO Per Share (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Price to CFO Per Share (TTM) Benchmarks

View Price to CFO Per Share (TTM) Benchmarks
Start Trial
Gilead Sciences, Inc. Upgrade
Revolution Medicines, Inc. --
Catalyst Pharmaceuticals, Inc. Upgrade
Regeneron Pharmaceuticals, Inc. Upgrade
Structure Therapeutics, Inc. --